Share

Leading the way to success, together

Our Board is responsible for the long-term success of Haleon, the Group's system of corporate governance and is ultimately accountable for the Group's activities, strategy, risk management and financial performance. 

Board and Committees

  • Sir Dave Lewis

    Chair

    Sir Dave Lewis

    Chair

    Appointed: 23 May 2022
    Committee membership: Nominations & Governance (Chair)

    Dave served as Group Chief Executive Officer of Tesco plc, a multinational retailer, from 2014 until September 2020.

    Prior to joining Tesco, he served for 28 years in a variety of management positions with Unilever plc, a global consumer products company. His last two roles, President Americas and Global President for Personal care were on the Global Executive team.

    Dave is a non-executive director with PepsiCo and Chairman of Xlinks, a privately owned renewable energy business. He also served on the Sky plc Board from 2012 to 2016. Dave also serves on the board of a non-profit and charitable organisation as Chair of the World Wildlife Fund-UK. He was also chair of Champions 12.3, a UN programme seeking to add momentum to the achievement of the UN Sustainable Development Target 12.3 by 2030, and co-chair of the Consumer, Retail and Life Sciences Business Council, which was established to advise the Prime Minister of the United Kingdom.

    In recognition of his contribution to business and the food industry in the United Kingdom, Dave was knighted by Her Majesty Queen Elizabeth II in the 2021 New Year’s Honours List.

  • Brian McNamara 

    Chief Executive Officer

    Brian McNamara 

    Chief Executive Officer

    Appointed: 23 May 2022

    Brian is the CEO of Haleon, having been appointed in July 2021. Prior to that, he had led the Consumer Healthcare business since 2016, while it was still part of GSK. He is focused on shaping a strategy for growth that puts purpose at its heart. He leads 23,000 employees across more than 100 countries, who are working every day to deliver better everyday health with humanity.

    Brian initially joined GSK Consumer Healthcare as Head of Europe and the Americas in 2015, Previously, he spent three years as the Over-the-Counter (OTC) Division Head at Novartis and a member of the Novartis Executive Committee, following a number of senior leadership roles across his ten-year tenure at the company. He began his career at Procter & Gamble, where over a 16-year tenure, he gained extensive experience in product supply, brand marketing, and customer leadership.

    Brian sits on Haleon’s Board of Directors. He is also a Board member of Mondelẽz International, Inc and the Consumer Goods Forum (CGF). He has previously served as a Board Member and Chairman of the Global Self Care Federation (GSCF) and an active member of the Board of Trustees for Treloar’s – a trust providing support and independence education for young people with physical disabilities.

    Favourite Haleon brand: Voltaren

  • Dawn Allen 

    Chief Financial Officer 

    Dawn Allen 

    Chief Financial Officer

    Dawn Allen assumed her role as Chief Financial Officer and Board member of Haleon in November 2024.  

    Dawn is a Chartered Accountant, with an extensive and proven track record of financial, international and consumer experience. She joins Haleon from Tate & Lyle plc where she was CFO and member of the Board and Executive Team. 

    Her previous experience includes a 25-year career at Mars Inc. where she was more recently Global CFO and Vice President of Global Transformation.  

    Dawn also serves as Non-Executive Director and member of the Audit & Risk Committee at the British media company ITV plc. 

    Favourite Haleon brand: Sensodyne

  • Manvinder Singh (Vindi) Banga

    Senior Independent Non-Executive Director

    Manvinder Singh (Vindi) Banga 

    Senior Independent Non-Executive Director

    Appointed: 18 July 2022
    Committee membership: Audit & Risk, Nominations & Governance and Remuneration.

    Before joining the Haleon Board, Vindi was Senior Independent Director at GSK and joined the GSK Board in September 2015. Additionally, he has been Chairman of UK Government Investments Limited (UKGI) since September 2021.

    Vindi has many years of commercial experience and a track record of delivering outstanding performance in highly competitive global consumer-focused businesses. Vindi spent 33 years at Unilever plc, where his last role was President of the Global Foods, Home and Personal Care businesses, and a member of the Unilever Executive Board. Vindi sat on the Prime Minister of India’s Council of Trade & Industry from 2004 to 2014 and was on the Board of Governors of the Indian Institute of Management (IIM), Ahmedabad.

    His prior non-executive roles include Non-Executive Director of the Confederation of British Industry (CBI) and Thomson Reuters Corp, Chairman of the Supervisory Board of Mauser Group, Chairman of Kalle GmbH, Senior Independent Director of Marks & Spencer Group plc and Chair, Exec Committee, Diversey Inc.

    Vindi’s external appointments include: Operating Partner, Clayton Dubilier & Rice LLC; Chair, UK Government Investments Limited; Non-Executive Director, The Economist Newspaper Limited; Member, Holdingham International Advisory Board; Board Member, International Chamber of Commerce UK; Member, Governing Board of the Indian School of Business, Hyderabad; Member, Global Leadership Council of Saïd Business School, Oxford; and Chair of the Board of Trustees, Marie Curie.

    Favourite Haleon brand: Voltaren

  • Nancy Avila 

    Independent Non-Executive Director

    Nancy Avila 

    Independent Non-Executive Director

    Appointed: 1 September 2024

    Committee membership: Audit & Risk

    Nancy has significant experience leading business transformations with technology, developing new digital channels for growth, modernising operations and addressing regulatory, technology, cyber and financial risk.

    Nancy has spent most of her career in technology and business operations in healthcare, life sciences, industrial, and distribution across several Fortune 100 companies, including McKesson Corporation, Johnson Controls Inc., and Abbott Laboratories Inc. Nancy is currently Chief Information Officer at Analog Devices, Inc.

    Nancy is an Independent Director of Comerica Incorporated.

    Favourite Haleon brand: Emergen-C 

  • Marie-Anne Aymerich 

    Independent Non-Executive Director

    Marie-Anne Aymerich 

    Independent Non-Executive Director and Chair of the Environmental & Social Sustainability Committee

    Appointed: 18 July 2022

    Committee membership: Environmental & Social Sustainability Committee (Chair)

    Marie-Anne has had a successful 30+ year international career spanning the consumer and luxury sectors, growing businesses, and shaping brands through innovation and creativity.

    Most recently, Marie-Anne led the worldwide Oral Care category at Unilever plc where she developed a portfolio of new premium brands. Prior to that Marie-Anne was Brand General Manager of LVMH Group’s (LVMH) Dior perfume and beauty business where she was responsible for strategy, brand equity, innovation, advertising, and digital. Before joining LVMH, Marie-Anne was Managing Director for Unilever’s Home and Personal Care business in France.

    Marie-Anne is a Non-Executive Director of Pierre Fabre Group and is a Trustee and Member of the Nomination Committee of The Academy of Saint Martin in the Fields.

    Favourite Haleon brand: Centrum

  • Tracy Clarke

    Independent Non-Executive Director

    Tracy Clarke

    Independent Non-Executive Director and Chair of the Remuneration Committee

    Appointed: 18 July 2022

    Committee membership: Audit & Risk, Nominations & Governance, Remuneration (Chair) and Environmental & Social Sustainability.

    Tracy is currently Non-Executive Director and Remuneration Committee Chair at TP ICAP plc, Senior Independent Director and Remuneration Committee Chair of Starling Bank, Chair of SchoolOnline, an online learning platform, and Advisor and Non-Executive Director at Acin Ltd.

    Tracy has considerable international banking, financial services, commercial and leadership experience, having held a range of senior executive positions over 30 years at Standard Chartered Bank, where her last role was Private Bank CEO and Regional CEO, Europe & Americas. During her time at Standard Chartered she served as a director of Standard Chartered Bank UK, a Non-Executive director of Standard Chartered First Bank in Korea, director of Zodia Holdings Limited and Zodia Custody Ltd. She also chaired the Supervisory Board of Standard Chartered Bank AG and Standard Chartered Yatirim Bankasi Turk A.S.

    Tracy is an experienced Remuneration Committee Chair and Non-Executive Director. Her prior non-executive roles include Chair of the Remuneration Committees of Sky plc and Eaga plc and Non-Executive Director and Remuneration Committee member of Inmarsat plc. She has also served on the boards of the China Britain Business Council and TheCityUK.

    Favourite Haleon brand: Voltaren

  • Dame Vivienne Cox

    Independent Non-Executive Director 

    Dame Vivienne Cox

    Independent Non-Executive Director and Workforce Engagement Director 

    Appointed: 18 July 2022

    Committee membership: Audit & Risk, Remuneration and Environmental & Social Sustainability

    Prior to joining the Haleon Board, Vivienne was an independent Non-Executive Director at GSK, a role she had held since July 2016, Vivienne had also been Workforce Engagement Director at GSK since January 2019.

    Vivienne has wide experience of business gained in the energy, natural resources, and publishing sectors. She also has a deep understanding of regulatory organisations and government. Vivienne worked for BP plc for 28 years, in Britain and Continental Europe, in posts including Executive Vice President and Chief Executive of BP’s gas, power and renewable business and its alternative energy unit. Vivienne was previously a Non-Executive Director of BG Group plc and Rio Tinto plc, the Senior Independent Director of Pearson plc, Chairman of the Supervisory Board of Vallourec and the Lead Independent Director at the UK Government’s Department for International Development.

    Vivienne’s external appointments include: Non-Executive Director, Venterra Group plc; Chair, Victrex plc; Non-Executive Director, African Leadership Institute; Advisory Board Member, Montrose Associates; Investment Advisor, QantX Ventures; Chair, Rosalind Franklin Institute; Vice Chair, Saïd Business School, Oxford and member of its Global Leadership Council, and Patron, Hospice of St Francis.

    Favourite Haleon brand: Centrum

  • Asmita Dubey

    Independent Non-Executive Director

    Asmita Dubey

    Independent Non-Executive Director

    Independent Non-Executive Director

    Appointed: 18 July 2022

    Asmita has over 25 years of experience working in consumer businesses. She has worked at L’Oréal Group since 2013 and is currently Chief Digital and Marketing Officer and a member of the L’Oréal Executive Committee.

    Asmita brings extensive expertise of marketing in the digital age and is leading L’Oréal on a digital transformation journey to evolve the marketing models, adopt new data-driven solutions, and accelerate emerging business models for the largest beauty company in the world.

    Asmita also brings strong experience working in China where she strengthened L’Oréal’s digital footprint in the region, built L’Oréal’s first joint-business partnerships with Alibaba Group and Tencent Holdings Ltd and established a broader start-up ecosystem.

    In addition to her executive career, Asmita served on the GSK Consumer Healthcare Digital Advisory Board.

    Favourite Haleon brand: Advil

  • Alan Stewart

    Independent Non-Executive Director

    Alan Stewart

    Independent Non-Executive Director and Chair of the Audit & Risk Committee

    Appointed: 1 September 2024

    Committee membership: Audit & Risk (Chair), Nominations & Governance, Environmental & Social Sustainability, and Remuneration.

    Alan joins the board with significant corporate finance, accounting and international experience from a wide range of consumer-related industries. He has extensive board and listed company experience.

    Alan is currently Non-Executive Director and Audit Committee Chair at Burberry Group plc. He was previously Non-Executive Director and Audit Committee Chair at Diageo plc, Non-Executive Director and Chair of the Remuneration Committee of Reckitt Benckiser Group PLC, and Non-Executive Director and Audit Committee Chair at Games Workshop Group plc. In his executive career, Alan was, inter alia, Chief Financial Officer of Tesco PLC and Marks & Spencer PLC.  

    Alan was a founder member of the Accounting 4 Sustainability CFO network and is currently a member of Chapter Zero, which is a community of non-executive directors committed to achieving net-zero targets. Alan is a qualified Chartered Accountant.

    Favourite Haleon brand: Aquafresh

  • Bryan Supran

    Non-Executive Director

    Bryan Supran

    Non-Executive Director

    Appointed: 18 July 2022

    Bryan brings considerable corporate, strategic and business development experience from over 25 years as a leading corporate and transactional attorney across consumer healthcare, pharmaceutical and life sciences.

    Since 2015, Bryan has served as Senior Vice President & Deputy General Counsel of Pfizer, a role that includes counselling management and the Board of Directors on strategic initiatives and business development transactions, such as Pfizer’s COVID-19 vaccine collaboration with BioNTech, the successful split-off of its animal health business as Zoetis, and the joint venture with GSK to create the premier global consumer healthcare business - now Haleon. Bryan served on the joint venture Board with GSK following the transaction with Pfizer until the demerger of Haleon.

    Bryan’s role also has included leadership of Pfizer’s intellectual property and international legal teams, as well as legal support for Pfizer’s R&D and manufacturing organizations. Previously, Bryan practiced law at Ropes & Gray LLP in Boston and New York, where he helped establish the firm’s life sciences practice.

    Favourite Haleon brand: Emergen-C

  • Brian McNamara

    Chief Executive Officer

    Brian McNamara

    Chief Executive Officer

    Brian is the CEO of Haleon, having been appointed in July 2021. Prior to that, he had led the Consumer Healthcare business since 2016, while it was still part of GSK. He is focused on shaping a strategy for growth that puts purpose at its heart. He leads Haleon's employees across more than 100 countries, who are working every day to deliver better everyday health with humanity.

    Brian initially joined GSK Consumer Healthcare as Head of Europe and the Americas in 2015, Previously, he spent three years as the Over-the-Counter (OTC) Division Head at Novartis and a member of the Novartis Executive Committee, following a number of senior leadership roles across his ten-year tenure at the company. He began his career at Procter & Gamble, where over a 16-year tenure, he gained extensive experience in product supply, brand marketing, and customer leadership.

    Brian sits on Haleon’s Board of Directors. He is also a Board member of Mondelẽz International, Inc and the Consumer Goods Forum (CGF). He has previously served as a Board Member and Chairman of the Global Self Care Federation (GSCF) and an active member of the Board of Trustees for Treloar’s – a trust providing support and independence education for young people with physical disabilities.

    Favourite Haleon brand: Voltaren

    Haleon is led by our purpose - to deliver better everyday health with humanity. We are committed to the hundreds of millions of people around the world who depend on and trust our products. Our purpose drives us to meet their everyday health needs in new and better ways, to make everyday health more achievable, inclusive and sustainable.

  • Dawn Allen 
    Chief Financial Officer 

    Dawn Allen 

    Chief Financial Officer

    Dawn Allen assumed her role as Chief Financial Officer and Board member of Haleon in November 2024.  

    Dawn is a Chartered Accountant, with an extensive and proven track record of financial, international and consumer experience. She joins Haleon from Tate & Lyle plc where she was CFO and member of the Board and Executive Team. 

    Her previous experience includes a 25-year career at Mars Inc. where she was more recently Global CFO and Vice President of Global Transformation.  

    Dawn also serves as Non-Executive Director and member of the Audit & Risk Committee at the British media company ITV plc. 

    Favourite Haleon brand: Sensodyne

  • Keith Choy

    President, Asia Pacific

    Keith Choy

    President, Asia Pacific

    Keith was appointed Head of Asia Pacific in 2019, while the business was still part of GSK.

    Before joining GSK, Keith was the President for International markets of Pfizer Consumer Healthcare (PCH). He previously served as the Regional President of APAC PCH and before that as China GM, where he oversaw significant sales growth in the China OTC category. Across his 28 years of commercial experience in the consumer-packaged goods and healthcare industries, Keith has also held various roles of sales, brand marketing, and general management in Wyeth, Gillette and Joyco (acquired by Wrigley Company).

    He was awarded the Internationalist of the Year for 2017.

    Favourite Haleon brand: Sensodyne

    Asia Pacific has the world’s largest population, and some of the fastest growing economies. Consumer habits are shifting, accelerated by the recent pandemic, meaning more people than ever are buying everyday healthcare products online. At Haleon, our approach of data driven insights helps make sure we’re getting the right products to the right people at the right time.

  • Line De Decker

    Chief Human Resources Officer

    Line De Decker

    Chief Human Resources Officer

    Line was appointed Chief Human Resources Officer in August 2024. 

    Line joined Haleon from Aliaxis, a global leader in creating sustainable solutions for water and energy, where she was Chief People and Sustainability Officer. 

    Line brings deep experience of operating in complex and regulated organisations during times of change and transformation. Her previous roles have included Senior Vice President and Head of Transformation at GSK, where she also held a series of HR roles within both its Consumer and Pharmaceutical divisions. 

    Line also held HR management roles at DuPont and started her career at PWC and UCB where she specialised in tax and reward.

    Line is a Non-Executive Director of medical imaging company Agfa-Gevaert.

    Favourite Haleon brand: Tums

  • Claire Dickson 

    Chief Digital and Technology Officer

    Claire Dickson

    Chief Digital and Technology Officer 

    Claire was appointed Chief Digital and Technology Officer in September 2024. 

    With more than 25 years’ experience working in technology, Claire joined Haleon from the FTSE-listed packaging business DS Smith, where she was Chief Information Officer. 

    In this role, Claire was accountable for building and deploying cyber secure and resilient operations across over 300 industrial facilities globally and unlocking growth by driving digital and data capabilities across machine, energy, supply chain and customer experience. 

    Her previous roles have included Chief Information Officer for BP’s Downstream business. 

    Favourite Haleon brand: Centrum

  • Filippo Lanzi

    President, EMEA and LATAM

    Filippo Lanzi

    President, EMEA and LATAM

    Filippo was appointed Head of EMEA and Latin America for Haleon in 2021, having previously served as EMEA Lead from 2019, while the business was still part of GSK.

    Having joined GSK in 2012, he has served in various roles across Southern, Central and Eastern Europe before leading the Asia Pacific business.

    Prior to joining GSK, he was the Operating Unit Head in Italy and Greece for Novartis’ OTC business. Previously, Filippo spent five years at Johnson & Johnson, managing the Diabetes Division in Italy and then as Head of Mediterranean Cluster for the Ethicon/ Endo Franchise. Before J&J, he spent a decade with Nestlé, holding various roles across Marketing, Sales and Finance.

    Favourite Haleon brand: Parodontax

    We know that technology touches every part of our lives, and everyday health is no exception. At Haleon, we are leveraging data, technology and insights to develop products and services that meet the needs of our consumers and customers around the world.

  • Adrian Morris

    General Counsel

    Adrian Morris

    General Counsel

    Adrian was appointed as General Counsel for Haleon in August 2024.  

    Adrian brings a wealth of expertise across all aspects of the legal, regulatory, compliance and governance agenda, including 11 years as Group General Counsel for Tesco PLC, the leading multinational retailer.  

    Prior to joining Tesco, Adrian was Associate General Counsel at BP PLC and before that was at Centrica PLC.  

    He is a Non-Executive Director of Moorfields Eye Hospital NHS Foundation Trust.

    Favourite Haleon Product: Centrum 

  • Lisa Paley

    President, North America

    Lisa Paley

    President, North America

    Lisa has led the North America Region since 2021, having previously been General Manager, U.S. and Puerto Rico, when the business was still part of GSK.

    She joined GSK in 2019 from Pfizer Consumer Healthcare, where she had been President of North America, responsible for the US, Puerto Rico and Canadian markets. In her decade at Pfizer, Lisa had senior roles in sales strategy; was General Manager of Puerto Rico & Caribbean; was the U.S. Chief Customer Officer and leader of Global E-Commerce.

    Previously, Lisa worked at Johnson & Johnson (J&J) as a Vice President in US Sales and also spent 18 years with the former Pfizer Consumer Healthcare/Warner Lambert where she held positions of increasing responsibility in Sales, Customer Development, Sales Strategy, Operations, Category Management & Insights and General Management.

    She is a former Certified Public Accountant and worked for Deloitte.

    Lisa is a Board member of several US industry association boards including CHPA Executive Committee, NACDS Retail Advisory Board, and the WE Board.

    Favourite Haleon brand: Emergen-C

    Our North American business has a world class portfolio of exceptional brands that are trusted by consumers again and again, for themselves and their families. These brands are at the centre of all we do, to help make everyday health more achievable, inclusive and sustainable for our consumers and customers.

  • Namrata Patel

    Chief Supply Chain Officer

    Namrata Patel

    Chief Supply Chain Officer

    Namrata was appointed Chief Supply Chain Officer in November 2023.

    Namrata joined Haleon from Procter & Gamble, where she spent 17 years in various leadership roles. This included spending six years leading Global Supply Chain for the company’s Beauty Sector, as well as leading the supply chain sustainability agenda for Procter & Gamble globally. Namrata also had supply chain leadership roles in Central Eastern Europe, Middle East & Africa, Western Europe and Latin America.

    Before joining Procter & Gamble, Namrata held senior leadership roles at global consumer companies including The Coca-Cola Company, Gillette and Procter & Gamble. Namrata is also a Non-Executive Director of Oxford Biomedica, a leading gene and cell therapy group.

    Favourite Haleon brand: Voltaren

    An agile and resilient Supply Chain is at the very heart of Haleon’s operations, and is vital to our continued success. In supplying to the millions of consumers we reach, we aim to deliver for today and build for tomorrow – driving excellence in all we do and putting people first.

  • Ed Petter 

    Chief Corporate Affairs Officer

    Ed Petter

    Chief Corporate Affairs Officer

    Ed was appointed to Haleon’s Executive Team in January 2024. As Chief Corporate Affairs Officer, he is responsible for delivering the company’s global Corporate Affairs agenda which encompasses external and internal engagement, issues and reputation management, government affairs, corporate and trade policy, sustainability and social impact.

    Prior to joining Haleon, Ed spent seven years at BT Group, the UK’s leading telecommunications and network provider, as Group Corporate Affairs Director and member of the Executive Committee.

    Ed brings extensive corporate affairs leadership experience from across a range of sectors, having held senior positions at Lloyds Banking Group and McDonald's, as well as previous consulting roles at McKinsey & Company and Blue Rubicon. He started his career as a journalist at the BBC.

    Favourite Haleon brand: Panadol

    Acting responsibly and being trusted by our key stakeholders are critical for Haleon to deliver its strategy and growth objectives. We therefore want to ensure they understand the impact and value that our category-leading brands bring to people and communities across the globe.

  • Franck Riot

    Chief R&D Officer

    Franck Riot

    Chief R&D Officer

    Franck was appointed Head of Global R&D in 2019, while the business was still part of GSK. Previously, Franck was Vice President of Research and Innovation at Danone for the Essential Dairy and Plant-Based World-Wide Business Unit from 2017-2019.

    Franck began his career as an R&D engineer in the beauty and personal care sector, then spent 14 years at Danone, with progressively larger R&D roles in Europe. He left Danone for six years to run the global R&D organisation for IGLO (owned by private equity Permira), which was sold to Nomad Foods. Franck was part of the Nomad Foods team that then took the company public in 2015, after which he returned to Danone to run research and innovation for the newly created EDP unit after the acquisition of the world leading plant-based food company WhiteWave (2017).

    Favourite Haleon brand: Voltaren

    We don’t just understand science. We understand people. That’s why we’ll never stop innovating to help you enjoy a better life.

  • Tamara Rogers

    Chief Marketing Officer

    Tamara Rogers

    Chief Marketing Officer

    Tamara was appointed Chief Marketing Officer in 2019, while the business was still part of GSK, having previously served as Region Head for EMEA.

    Prior to joining GSK, Tamara spent nearly 25 years at Unilever, having joined as a Management Trainee in the UK. She held significant leadership positions such as EVP Region Head Personal Care for Unilever North America and prior to that, EVP Global Deodorants Category.

    Tamara has 30 years of experience in FMCG with numerous commercial roles across marketing, advertising, customer development and general management, in local, regional and global capacities. Her experience includes the development of business growth strategies, strategic portfolio management, innovation development, brand branding, design, customer development and trade marketing. Her responsibilities have also included Media, Consumer Business Insights & Analytics, Marketing and Digital Commerce capability.

    Tamara is a Board Member of the Global Self-Care Federation, which exists to create a healthier world through better self-care.

    Favourite Haleon brand: Advil

    Everything starts with our brands. We build brands with humanity. Brands that serve consumers’ everyday health needs. Brands trusted by Healthcare Professionals and consumers alike.

  • Björn Timelin

    Head of Strategy

    Björn Timelin

    Head of Strategy

    Björn was appointed Head of Strategy in October 2023.

    Björn joined Haleon from McKinsey, where he was a Senior Partner specialising in strategic and commercial topics for consumer-facing companies, with clients across the retail, consumer packaged goods, media, and luxury goods sectors.

    Prior to joining McKinsey, Björn spent four years at Procter & Gamble’s beauty-care division in the UK and Switzerland.

    Favourite Haleon brand: Voltaren

    At Haleon, our strategy is designed to leverage our world-class portfolio and competitive capabilities. It brings clarity to the choices we make and helps guide us in delivering our purpose to deliver better everyday health with humanity.

Related

You may also be interested in